The vaccines market reached a value of nearly $92,607.6 million in 2021, having grown at a compound annual growth rate (CAGR) of 8.1% since 2016. The market is expected to grow from $92,607.6 million in 2021 to $150,931.3 million in 2026 at a rate of 10.3%. The market is then expected to grow at a CAGR of 9.0% from 2026 and reach $232,624.0 million in 2031.
Growth in the historic period resulted from increased healthcare access, the coronavirus outbreak, continuous protection towards infectious diseases and increased awareness of immunization.
Going forward, increasing cases of invasive cervical cancer, strong late-stage pipeline and new vaccine approvals, increasing prevalence of infectious diseases among children, emergence of zoonotic diseases and vaccine resistant mutations will drive the growth. Factors that could hinder the growth of the vaccines market in the future include skilled workforce shortages and high cost of vaccines.
The vaccines market is segmented by type into anti-infective vaccines, anti-cancer vaccines, and other types. The anti-infective vaccines market was the largest segment of the vaccines market segmented by type, accounting for 85.9% of the total in 2021. Going forward, the anti-cancer vaccines market is expected to be the fastest growing segment in the vaccines market segmented by type, at a CAGR of 10.7% during 2021-2026.
The vaccines market is segmented by technology into conjugate vaccines, inactivated and subunit vaccines, live attenuated vaccines, recombinant vaccines, toxoid vaccines, and other technologies. The conjugate vaccines market was the largest segment of the vaccines market segmented by technology accounting for 43.9% of the total in 2021. Going forward, the other technologies market is expected to be the fastest growing segment in the vaccines market segmented by technology, at a CAGR of 17.7% during 2021-2026.
The vaccines market is segmented by route of administration into intramuscular (IM), subcutaneous (SC), oral, and other route of administration. The intramuscular (IM) market was the largest segment of the vaccines market segmented by route of administration, accounting for 47.5% of the total in 2021. Going forward, the intramuscular (IM) market is expected to be the fastest growing segment in the vaccines market segmented by route of administration, at a CAGR of 11.0% during 2021-2026.
The vaccines market is segmented by valance into monovalent, and multivalent. The multivalent market was the largest segment of the vaccines market segmented by valance, accounting for 61.5% of the total in 2021. Going forward, the multivalent market is expected to be the fastest growing segment in the vaccines market segmented by valance, at a CAGR of 10.8% during 2021-2026.
The vaccines market is segmented by distribution channel into hospital pharmacies, retail pharmacies, and institutional sales. The hospital pharmacies market was the largest segment of the vaccines market segmented by distribution channel, accounting for 30.5% of the total in 2021. Going forward, the institutional sales market is expected to be the fastest growing segment in the vaccines market segmented by distribution channel, at a CAGR of 12.7% during 2021-2026.
North America was the largest region in the vaccines market, accounting for 53.7% of the total in 2021. It was followed by Asia Pacific, and then the other regions. Going forward, the fastest-growing regions in the vaccines market will be Middle East, and, South America where growth will be at CAGRs of 14.6% and 13.0% respectively. These will be followed by Asia Pacific, and, Africa where the markets are expected to grow at CAGRs of 11.6% and 10.9% respectively.
The vaccines market is highly consolidated with a small number of global players dominating the market. The key players in the market are focusing on expanding their operational and business presence in the vaccine market through development of advanced technologies, strategic collaborations and establishments of new production plants to meet the global demand. The top ten competitors in the market made up to 82.34% of the total market in 2021. Pfizer Inc. was the largest competitor with 46.03% share of the market, followed by Merck & Co., Inc. with 10.46%, GlaxoSmithKline plc with 9.77%, Sanofi S.A. with 8.06%, AstraZeneca with 4.57%, CSL Limited with 1.92%, Serum Institute of India Pvt. Ltd. with 0.54%, Emergent BioSolutions Inc. with 0.50%, Daiichi Sankyo Company, Limited with 0.37%, and Bavarian Nordic with 0.11%.
The top opportunities in the vaccines market segmented by type will arise in the anti-infective vaccines segment, which will gain $49,866.9 million of global annual sales by 2026. The top opportunities in segment by technology will arise in the conjugate vaccines segment, which will gain $26,610.1 million of global annual sales by 2026. The top opportunities in segment by route of administration will arise in the intramuscular (IM) segment, which will gain $30,201.7 million of global annual sales by 2026. The top opportunities in segment by valence will arise in the multivalent segment, which will gain $38,172.2 million of global annual sales by 2026. The top opportunities in segment by distribution channel will arise in the hospital pharmacies segment, which will gain $37,872.6 million of global annual sales by 2026. The vaccines market size will gain the most in the USA at $27,549.2 million.
Market-trend-based strategies for the vaccines market include focusing on synthetic biology to aid in drug discovery processes to help understand the molecular mechanisms of target diseases, developing combination vaccines for protection against multiple diseases, focusing on robust research and development to continuously strive to make breakthroughs, leveraging artificial intelligence for vaccine development, focusing on development of conjugate vaccines for the prevention of bacterial infections and focusing on partnerships and acquisitions for expanding market presence and reach.
Player-adopted strategies in the vaccines market include strengthening portfolio of products, expanding market presence through collaborations and partnerships, enhancing geographic presence through strategic acquisitions and focusing on new product launches.
To take advantage of the opportunities, the publisher recommends the companies in the vaccines market to focus on development of combination vaccines, focus on research and development, focus on artificial intelligence, expand in emerging markets, continue to focus on developed markets, focus on partnerships and collaborations, provide competitively priced offerings, participate in trade shows and events, continue to use business-to-business (B2B) promotions and continue to target fast-growing end-users.
This report describes and explains the vaccines market and covers 2016 to 2021, termed the historic period, and 2021 to 2026 termed the forecast period, along with further forecasts for the period 2026-2031. The report evaluates the market across each region and for the major economies within each region.
Growth in the historic period resulted from increased healthcare access, the coronavirus outbreak, continuous protection towards infectious diseases and increased awareness of immunization.
Going forward, increasing cases of invasive cervical cancer, strong late-stage pipeline and new vaccine approvals, increasing prevalence of infectious diseases among children, emergence of zoonotic diseases and vaccine resistant mutations will drive the growth. Factors that could hinder the growth of the vaccines market in the future include skilled workforce shortages and high cost of vaccines.
The vaccines market is segmented by type into anti-infective vaccines, anti-cancer vaccines, and other types. The anti-infective vaccines market was the largest segment of the vaccines market segmented by type, accounting for 85.9% of the total in 2021. Going forward, the anti-cancer vaccines market is expected to be the fastest growing segment in the vaccines market segmented by type, at a CAGR of 10.7% during 2021-2026.
The vaccines market is segmented by technology into conjugate vaccines, inactivated and subunit vaccines, live attenuated vaccines, recombinant vaccines, toxoid vaccines, and other technologies. The conjugate vaccines market was the largest segment of the vaccines market segmented by technology accounting for 43.9% of the total in 2021. Going forward, the other technologies market is expected to be the fastest growing segment in the vaccines market segmented by technology, at a CAGR of 17.7% during 2021-2026.
The vaccines market is segmented by route of administration into intramuscular (IM), subcutaneous (SC), oral, and other route of administration. The intramuscular (IM) market was the largest segment of the vaccines market segmented by route of administration, accounting for 47.5% of the total in 2021. Going forward, the intramuscular (IM) market is expected to be the fastest growing segment in the vaccines market segmented by route of administration, at a CAGR of 11.0% during 2021-2026.
The vaccines market is segmented by valance into monovalent, and multivalent. The multivalent market was the largest segment of the vaccines market segmented by valance, accounting for 61.5% of the total in 2021. Going forward, the multivalent market is expected to be the fastest growing segment in the vaccines market segmented by valance, at a CAGR of 10.8% during 2021-2026.
The vaccines market is segmented by distribution channel into hospital pharmacies, retail pharmacies, and institutional sales. The hospital pharmacies market was the largest segment of the vaccines market segmented by distribution channel, accounting for 30.5% of the total in 2021. Going forward, the institutional sales market is expected to be the fastest growing segment in the vaccines market segmented by distribution channel, at a CAGR of 12.7% during 2021-2026.
North America was the largest region in the vaccines market, accounting for 53.7% of the total in 2021. It was followed by Asia Pacific, and then the other regions. Going forward, the fastest-growing regions in the vaccines market will be Middle East, and, South America where growth will be at CAGRs of 14.6% and 13.0% respectively. These will be followed by Asia Pacific, and, Africa where the markets are expected to grow at CAGRs of 11.6% and 10.9% respectively.
The vaccines market is highly consolidated with a small number of global players dominating the market. The key players in the market are focusing on expanding their operational and business presence in the vaccine market through development of advanced technologies, strategic collaborations and establishments of new production plants to meet the global demand. The top ten competitors in the market made up to 82.34% of the total market in 2021. Pfizer Inc. was the largest competitor with 46.03% share of the market, followed by Merck & Co., Inc. with 10.46%, GlaxoSmithKline plc with 9.77%, Sanofi S.A. with 8.06%, AstraZeneca with 4.57%, CSL Limited with 1.92%, Serum Institute of India Pvt. Ltd. with 0.54%, Emergent BioSolutions Inc. with 0.50%, Daiichi Sankyo Company, Limited with 0.37%, and Bavarian Nordic with 0.11%.
The top opportunities in the vaccines market segmented by type will arise in the anti-infective vaccines segment, which will gain $49,866.9 million of global annual sales by 2026. The top opportunities in segment by technology will arise in the conjugate vaccines segment, which will gain $26,610.1 million of global annual sales by 2026. The top opportunities in segment by route of administration will arise in the intramuscular (IM) segment, which will gain $30,201.7 million of global annual sales by 2026. The top opportunities in segment by valence will arise in the multivalent segment, which will gain $38,172.2 million of global annual sales by 2026. The top opportunities in segment by distribution channel will arise in the hospital pharmacies segment, which will gain $37,872.6 million of global annual sales by 2026. The vaccines market size will gain the most in the USA at $27,549.2 million.
Market-trend-based strategies for the vaccines market include focusing on synthetic biology to aid in drug discovery processes to help understand the molecular mechanisms of target diseases, developing combination vaccines for protection against multiple diseases, focusing on robust research and development to continuously strive to make breakthroughs, leveraging artificial intelligence for vaccine development, focusing on development of conjugate vaccines for the prevention of bacterial infections and focusing on partnerships and acquisitions for expanding market presence and reach.
Player-adopted strategies in the vaccines market include strengthening portfolio of products, expanding market presence through collaborations and partnerships, enhancing geographic presence through strategic acquisitions and focusing on new product launches.
To take advantage of the opportunities, the publisher recommends the companies in the vaccines market to focus on development of combination vaccines, focus on research and development, focus on artificial intelligence, expand in emerging markets, continue to focus on developed markets, focus on partnerships and collaborations, provide competitively priced offerings, participate in trade shows and events, continue to use business-to-business (B2B) promotions and continue to target fast-growing end-users.
This report describes and explains the vaccines market and covers 2016 to 2021, termed the historic period, and 2021 to 2026 termed the forecast period, along with further forecasts for the period 2026-2031. The report evaluates the market across each region and for the major economies within each region.
Table of Contents
1. Executive Summary2. Table Of Contents
3. List Of Figures
4. List Of Tables
5. Report Structure
6. Introduction And Market Characteristics
6.1. General Market Definition
6.2. Summary
6.3. Vaccines Market Definition And Segmentations
6.4. Market Segmentation By Type
6.4.1. Anti-Infective Vaccines
6.4.2. Anti-Cancer Vaccines
6.4.3. Other Types
6.5. Market Segmentation By Technology
6.5.1. Conjugate Vaccines
6.5.2. Inactivated And Subunit Vaccines
6.5.3. Live Attenuated Vaccines
6.5.4. Recombinant Vaccines
6.5.5. Toxoid Vaccines
6.5.6. Other Technologies
6.6. Market Segmentation By Route Of Administration
6.6.1. Intramuscular (IM)
6.6.2. Subcutaneous (SC)
6.6.3. Oral
6.6.4. Other Route of Administration
6.7. Market Segmentation By Valance
6.7.1. Monovalent
6.7.2. Multivalent
6.8. Market Segmentation By Distribution Channel
6.8.1. Hospital Pharmacies
6.8.2. Retail Pharmacies
6.8.3. Institutional Sales
7. Major Market Trends
7.1. Synthetic Biology In Vaccine Development
7.2. Development Of Combination Vaccines
7.3. Robust Research And Development
7.4. Increasing Demand For Conjugate Vaccines
7.5. Artificial Intelligence In Vaccine Development
7.6. mRNA Vaccines
7.7. Cancer Vaccines
7.8. Increasing Acquisitions And Partnerships
8. Global Market Size And Growth
8.1. Market Size
8.2. Historic Market Growth, 2016 - 2021, Value ($ Million)
8.2.1. Market Drivers 2016 - 2021
8.2.2. Market Restraints 2016 - 2021
8.3. Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
8.3.1. Market Drivers 2021 - 2026
8.3.2. Market Restraints 2021 - 2026
9. Global Vaccines Market Segmentation
9.1. Global Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
9.2. Global Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
9.3. Global Vaccines Market, Segmentation By Route Of Administration, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
9.4. Global Vaccines Market, Segmentation By Valence, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
9.5. Global Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
10. Vaccines Market, Regional and Country Analysis
10.1. Global Vaccines Market, By Region, Historic and Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
10.2. Global Vaccines Market, By Country, Historic and Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11. Asia-Pacific Market
11.1. Summary
11.2. Market Overview
11.2.1. Region Information
11.2.2. Market Information
11.2.3. Background Information
11.2.4. Government Initiatives
11.2.5. Regulations
11.2.6. Regulatory Bodies
11.2.7. Major Associations
11.2.8. Taxes Levied
11.2.9. Corporate Tax Structure
11.2.10. Investments
11.2.11. Major Companies
11.3. Asia-Pacific Vaccines Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.4. Asia-Pacific Vaccines Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.5. Asia-Pacific Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.6. Asia-Pacific Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.7. Asia-Pacific Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.8. Asia-Pacific Vaccines Market: Country Analysis
11.9. China Market
11.10. Summary
11.11. Market Overview
11.11.1. Country Information
11.11.2. Market Information
11.11.3. Background Information
11.11.4. Government Initiatives
11.11.5. Regulations
11.11.6. Regulatory Bodies
11.11.7. Major Associations
11.11.8. Taxes Levied
11.11.9. Corporate Tax Structure
11.11.10. Investments
11.11.11. Major Companies
11.12. China Vaccines Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.13. China Vaccines Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.14. China Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.15. China Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.16. China Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.17. India Market
11.18. India Vaccines Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.19. India Vaccines Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.20. India Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.21. India Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.22. India Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.23. Japan Market
11.24. Japan Vaccines Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.25. Japan Vaccines Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.26. Japan Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.27. Japan Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.28. Japan Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.29. Australia Market
11.30. Australia Vaccines Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.31. Australia Vaccines Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.32. Australia Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.33. Australia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.34. Australia Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.35. Indonesia Market
11.36. Indonesia Vaccines Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.37. Indonesia Vaccines Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.38. Indonesia Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.39. Indonesia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.40. Indonesia Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.41. South Korea Market
11.42. South Korea Vaccines Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.43. South Korea Vaccines Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.44. South Korea Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.45. South Korea Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.46. South Korea Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12. Western Europe Market
12.1. Summary
12.2. Market Overview
12.2.1. Region Information
12.2.2. Market Information
12.2.3. Background Information
12.2.4. Government Initiatives
12.2.5. Regulations
12.2.6. Regulatory Bodies
12.2.7. Major Associations
12.2.8. Taxes Levied
12.2.9. Corporate Tax Structure
12.2.10. Investments
12.2.11. Major Companies
12.3. Western Europe Vaccines Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
12.4. Western Europe Vaccines Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
12.5. Western Europe Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.6. Western Europe Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.7. Western Europe Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.8. Western Europe Vaccines Market: Country Analysis
12.9. UK Market
12.10. UK Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
12.11. UK Vaccines Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
12.12. UK Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.13. UK Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.14. UK Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.15. Germany Market
12.16. Germany Vaccines Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
12.17. Germany Vaccines Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
12.18. Germany Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.19. Germany Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.20. Germany Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.21. France Market
12.22. France Vaccines Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
12.23. France Vaccines Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
12.24. France Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.25. France Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.26. France Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13. Eastern Europe Market
13.1. Summary
13.2. Market Overview
13.2.1. Region Information
13.2.2. Market Information
13.2.3. Background Information
13.2.4. Government Initiatives
13.2.5. Regulations
13.2.6. Regulatory Bodies
13.2.7. Major Associations
13.2.8. Taxes Levied
13.2.9. Corporate Tax Structure
13.2.10. Investments
13.2.11. Major Companies
13.3. Eastern Europe Vaccines Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
13.4. Eastern Europe Vaccines Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
13.5. Eastern Europe Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.6. Eastern Europe Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.7. Eastern Europe Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.8. Eastern Europe Vaccines Market: Country Analysis
13.9. Russia Market
13.10. Russia Vaccines Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
13.11. Russia Vaccines Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
13.12. Russia Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.13. Russia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.14. Russia Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14. North America Market
14.1. Summary
14.2. Market Overview
14.2.1. Region Information
14.2.2. Market Information
14.2.3. Background Information
14.2.4. Government Initiatives
14.2.5. Regulations
14.2.6. Regulatory Bodies
14.2.7. Major Associations
14.2.8. Taxes Levied
14.2.9. Corporate Tax Structure
14.2.10. Investments
14.2.11. Major Companies
14.3. North America Vaccines Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
14.4. North America Vaccines Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
14.5. North America Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.6. North America Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.7. North America Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.8. North America Vaccines Market: Country Analysis
14.9. USA Market
14.10. Summary
14.11. Market Overview
14.11.1. Country Information
14.11.2. Market Information
14.11.3. Background Information
14.11.4. Government Initiatives
14.11.5. Regulations
14.11.6. Regulatory Bodies
14.11.7. Major Associations
14.11.8. Taxes Levied
14.11.9. Corporate Tax Structure
14.11.10. Investments
14.11.11. Major Companies
14.12. USA Vaccines Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
14.13. USA Vaccines Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
14.14. USA Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.15. USA Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.16. USA Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15. South America Market
15.1. Summary
15.2. Market Overview
15.2.1. Region Information
15.2.2. Market Information
15.2.3. Background Information
15.2.4. Government Initiatives
15.2.5. Regulations
15.2.6. Regulatory Bodies
15.2.7. Major Associations
15.2.8. Taxes Levied
15.2.9. Corporate Tax Structure
15.2.10. Investments
15.2.11. Major Companies
15.3. South America Vaccines Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
15.4. South America Vaccines Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
15.5. South America Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.6. South America Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.7. South America Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.8. South America Vaccines Market: Country Analysis
15.9. Brazil Market
15.10. Brazil Vaccines Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
15.11. Brazil Vaccines Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
15.12. Brazil Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.13. Brazil Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.14. Brazil Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
16. Middle East Market
16.1. Summary
16.2. Market Overview
16.2.1. Region Information
16.2.2. Market Information
16.2.3. Background Information
16.2.4. Government Initiatives
16.2.5. Regulations
16.2.6. Regulatory Bodies
16.2.7. Major Associations
16.2.8. Taxes Levied
16.2.9. Corporate Tax Structure
16.2.10. Investments
16.2.11. Major Companies
16.3. Middle East Vaccines Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
16.4. Middle East Vaccines Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
16.5. Middle East Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
16.6. Middle East Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
16.7. Middle East Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
17. Africa Market
17.1. Summary
17.2. Market Overview
17.2.1. Region Information
17.2.2. Market Information
17.2.3. Background Information
17.2.4. Government Initiatives
17.2.5. Regulations
17.2.6. Regulatory Bodies
17.2.7. Major Associations
17.2.8. Taxes Levied
17.2.9. Corporate Tax Structure
17.2.10. Investments
17.2.11. Major Companies
17.3. Africa Vaccines Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
17.4. Africa Vaccines Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
17.5. Africa Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
17.6. Africa Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
17.7. Africa Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
18. Competitive Landscape and Company Profiles
19. Company Profiles
19.1. Pfizer Inc
19.1.1. Company Overview
19.1.2. Products And Services
19.1.3. Business Strategy
19.1.4. Financial Overview
19.2. Merck & Co., Inc
19.2.1. Company Overview
19.2.2. Products And Services
19.2.3. Business Strategy
19.2.4. Financial Overview
19.3. GlaxoSmithKline plc
19.3.1. Company Overview
19.3.2. Products And Services
19.3.3. Business Strategy
19.3.4. Financial Overview
19.4. Sanofi S. A
19.4.1. Company Overview
19.4.2. Products And Services
19.4.3. Business Strategy
19.4.4. Financial Overview
19.5. AstraZeneca plc
19.5.1. Company Overview
19.5.2. Products And Services
19.5.3. Business Strategy
19.5.4. Financial Overview
20. Pipeline Analysis
21. Key Mergers And Acquisitions
21.1. GSK plc Acquired Affinivax Inc
21.2. Ceva Santé Animale Acquired Artemis Technologies Inc.
21.3. Pfizer Inc. Acquired ReViral Ltd.
21.4. NEC OncoImmunity AS Acquired Vaximm AG’s Neoantigen Vaccine Development Assets.
21.5. Sanofi S. A. To Acquire Origimm Biotechnology GmbH
21.6. Vaccitech plc Acquired Avidea Technologies, Inc.
21.7. Shanghai Fosun Pharmaceutical Co., Ltd. Acquired Chengdu Antejin Biotech Co. Ltd.
21.8. Sanofi S. A. Acquired Translate Bio, Inc.
21.9. Thermo Fisher Scientific Inc. Acquired Viral Vector Manufacturing Business from Novasep SAS
21.10. Merck KGaA’s Life Sciences Company MilliporeSigma Acquired AmpTec
21.11. Sanofi S. A. Acquired Kymab Ltd
21.12. BioNTech SE Acquired GMP Certified Manufacturing Site of Novartis AG
21.13. GlaxoSmithKline plc Acquired 10% Stake In CureVac For $163.67 million
21.14. Merck & Co., Inc. Acquired Themis Bioscience GmbH
21.15. Novavax, Inc. Acquired Praha Vaccines For $167 million
21.16. Bavarian Nordic A/S Acquired Global Rights for Two Vaccines from GSK For $940.07 Million
21.17. Bharat Biotech International Limited Acquired Chiron Behring Vaccines from GlaxoSmithKline
22. Global Vaccines Market Opportunities And Strategies
22.1. Global Vaccines Market In 2026 - Countries Offering Most New Opportunities
22.2. Global Vaccines Market In 2026 - Segments Offering Most New Opportunities
22.3. Global Vaccines Market In 2026 - Growth Strategies
22.3.1. Market Trend Based Strategies
22.3.2. Competitor Strategies
23. Vaccines Market, Conclusions And Recommendations
23.1. Conclusions
23.2. Recommendations
23.2.1. Product
23.2.2. Place
23.2.3. Price
23.2.4. Promotion
23.2.5. People
24. Appendix
24.1. Market Data Sources
24.2. Research Methodology
24.3. Currencies
24.4. About the Publisher
24.5. Copyright and Disclaimer
Executive Summary
Vaccines Global Market Opportunities And Strategies To 2031 provides the strategists; marketers and senior management with the critical information they need to assess the global vaccines market as it emerges from the COVID-19 shut down.Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider vaccines market; and compares it with other markets.
The report covers the following chapters:
- Introduction and Market Characteristics: Brief introduction to the segmentations covered in the market, definitions and explanations about vaccines market.
- Key Trends: Highlights the major trends shaping the global vaccines market. This section also highlights likely future developments in the market.
- Global Market Size and Growth: Global historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
- Regional Analysis: Historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values and growth and market share comparison by region.
- Market Segmentation: Contains the market values (2016-2031) and analysis for for segment by type, segmentation by technology, segmentation by route of administration, segmentation by valance and segmentation by distribution channel in the market.
- Regional Market Size and Growth: Regional market size (2021), historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
- Competitive Landscape: Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
- Pipeline Analysis: Briefs on the pipeline analysis of vaccines from the major players in the market.
- Key Mergers and Acquisitions: Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
- Market Opportunities And Strategies - Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
- Conclusions And Recommendations - This section Includes recommendations for vaccines providers in terms of product/service offerings, geographic expansion, marketing strategies and target groups.
- Appendix: This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Scope
Markets Covered
1) By Type: Anti-Infective Vaccines; Anti-Cancer Vaccines; Other Types2) By Technology: Conjugate Vaccines; Inactivated And Subunit Vaccines; Live Attenuated Vaccines; Recombinant Vaccines; Toxoid Vaccines; Other Technologies
3) By Route Of Administration: Intramuscular (IM); Subcutaneous (SC); Oral; Other Route of Administration
4) By Valance: Monovalent; Multivalent
5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Institutional Sales
Companies Mentioned: Pfizer Inc.; Merck & Co., Inc.; GlaxoSmithKline plc; Sanofi S.A.; AstraZeneca
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time-series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; vaccines indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; vaccines market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Pfizer Inc.
- Merck & Co., Inc.
- GlaxoSmithKline plc
- Sanofi S.A.
- AstraZeneca
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 343 |
| Published | January 2023 |
| Forecast Period | 2021 - 2031 |
| Estimated Market Value ( USD | $ 92607.6 Million |
| Forecasted Market Value ( USD | $ 232624 Million |
| Compound Annual Growth Rate | 9.6% |
| Regions Covered | Global |
